PCSA Net Margin

The Net Margin of Processa Pharmaceuticals Inc (PCSA) is -6720.00%.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

PCSA Net Margin - Historical Value

Date	Value
2024-12-31	-6720.00%
2023-12-31	-6720.00%
2022-12-31	-2957.85%

PCSA Net Margin - Peers Comparison

Ticker	Name	Value
COOL.CN	Core One Labs Inc	-3485.34%
ETON	Eton Pharmaceuticals Inc	-9.80%
ALID	Allied Corp	-4134.10%
ELAN	Elanco Animal Health Inc	7.61%
EYEN	Eyenovia Inc	-86882.51%
LLY	Eli Lilly and Co	23.51%
PFE	Pfizer Inc	12.62%
KHRN.V	Khiron Life Sciences Corp	-258.92%
VTRS	Viatris Inc	-4.30%
BMY	Bristol-Myers Squibb Co	-18.53%
BRCK.U.CN	BellRock Brands Inc	-181.49%
CURR	CURRENC Group Inc	-85.01%
PRPH	Prophase Labs Inc	-788.24%
ZTS	Zoetis Inc	26.86%
ASP.TO	Acerus Pharmaceuticals Corporation	-1594.39%
CTLT	Catalent Inc	-23.81%
FLWR.V	Flowr Corp	-692.68%
EVOK	Evoke Pharma Inc	-52.22%
HUGE.CN	FSD Pharma Inc	-19519.39%
NGW.CN	Next Green Wave Holdings Inc	27.40%
SCYX	SCYNEXIS Inc	-568.29%
CRDL.TO	Cardiol Therapeutics Inc	-39550.00%
FONE.CN	Flower One Holdings Inc	-41.89%
MRK	Merck & Co Inc	26.68%
SOL.CN	SOL Global Investments Corp	133.62%
RPRX	Royalty Pharma PLC	37.95%
SHWZ	Medicine Man Technologies Inc	-20.03%
XPHY.CN	Xphyto Therapeutics Corp	-7203.18%
BAMM.CN	Body and Mind Inc	-92.14%
COCP	Cocrystal Pharma Inc	-480.10%
EBM.V	Eastwood Bio-Medical Canada Inc	-64.93%
JNJ	Johnson & Johnson	15.84%
ROMJ.V	Rubicon Organics Inc	-5.26%